
About Ebri
Ebri is an Education company based in Italy founded in 2002. Neuroscience research and therapeutic strategies for neurological diseases are conducted. Ebri offers products and services including Brain Research and Scientific Dissemination. Its focus areas include Continuing Education Centres. Its legal entity is Fondazione EBRI Rita Levi-Montalcini.
Company details
Conducts neuroscience research and develops therapeutic strategies for neurological diseases. Research focuses on the molecular and cellular mechanisms of nerve cells, synapses, and circuits. This work includes developing new diagnostic biomarkers and therapeutic approaches for neurological and neurodegenerative diseases such as Alzheimers disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, chronic pain, and pediatric neurodevelopmental disorders. A multidisciplinary approach is used, employing cutting-edge experimental and computational techniques. The institute fosters collaborations with national and international research and clinical centers to create synergies and promote multidisciplinary scientific approaches. The organization is also actively involved in scientific dissemination.
- Latest Funding Round$382.94K (USD), Grant
Apr 2018
- Investors
Products & Services of Ebri
Ebri offers a comprehensive portfolio of products and services, including Brain Research and Scientific Dissemination.
Brain research is conducted at EBRI to explore mechanisms of neurodegenerative diseases and develop diagnostic biomarkers.
Scientific dissemination is carried out by EBRI through lectures and media to promote understanding of neuroscience and its applications.
Apps and channels of Ebri
its YouTube channel Fondazione EBRI Rita Levi Montalcini has 484 subscribers and 30 videos.
Videos from Ebri
The most watched videos on Ebri's YouTube channel, Fondazione EBRI Rita Levi Montalcini (484 subscribers). Click a video to play it here.
More on Fondazione EBRI Rita Levi Montalcini.
Funding Insights of Ebri
- Total Rounds 6
- Last Round Grant β $382,940
- Investors Count 1
All 6 funding rounds of Ebri with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $382,940 | Grant | β | β | |
| Jan 2018 | $375,308 | Grant | β | β | |
| Jan 2018 | Grant | β | β | ||
| Jan 2017 | $403,405 | Grant | β | β | |
| Apr 2016 | $277,205 | Grant | β | β | |
| Apr 2014 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Ebri
Ebri has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Ebri
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ebri
3 dated milestones of Ebri across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Ebri is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $383K.
Web traffic of Ebri
The website of Ebri (ebri.it) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 13.7% vs previous month
Websites whose visitors overlap most with Ebri. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| femtonics.eu | 69% | 2.9K | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ebri
Ebri was founded in 2002 and raised its 1st funding round 12 years after it was founded.
Ebri is headquartered in Italy.
Conducts neuroscience research and develops therapeutic strategies for neurological diseases. Research focuses on the molecular and cellular mechanisms of nerve cells, synapses, and circuits. This work includes developing new diagnostic biomarkers and therapeutic approaches for neurological and neurodegenerative diseases such as Alzheimers disease, dementia, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, chronic pain, and pediatric neurodevelopmental disorders. A multidisciplinary approach is used, employing cutting-edge experimental and computational techniques. The institute fosters collaborations with national and international research and clinical centers to create synergies and promote multidisciplinary scientific approaches. The organization is also actively involved in scientific dissemination.
Ebri offers Brain Research and Scientific Dissemination.
Ebri has 1 investor. Key investors include European Union.
Ebri operates through Fondazione Ebri Rita Levi-Montalcini.